🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immunocompromised Patients

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT) NCT06755814n/a1 site📍 Milan Societa Italiana di Pneumologia T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients NCT05141058Phase 12 sites📍 Washington D.C.📍 Baltimore Children's National Research Institute · Tests: Coronavirus-specific T cell (CST) Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients NCT06890078n/a4 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Biological sampling RSV Vaccination in Immunocompromised Patients. NCT06597916Phase 21 site📍 Vienna Medical University of Vienna · Tests: Arexvy powder and suspension for injection Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients NCT07110636NA6 sites📍 San Francisco📍 New Orleans📍 Boston Karius, Inc. · Tests: Metagenomic plasma-based test for agnostic pathogen detection Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) NCT05026138n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Remote Temperature Monitoring of Patients At Risk for Developing Fever NCT06752512NA1 site📍 Schenectady AION Biosystems · Tests: Remote Patient Monitoring A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised NCT07013474Phase 3159 sites📍 Canoga Park📍 Granada Hills📍 La Jolla Pfizer · Tests: ibuzatrelvir, remdesivir, placebo for ibuzatrelvir, placebo for remdesivir Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations NCT07120464n/a1 site📍 Shenzhen Liaoning Chengda Biotechnology CO., LTD · Tests: Observation Only Third Party Viral Specific T-cells (VSTs) NCT02532452Phase 24 sites📍 Akron📍 Cincinnati📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Viral Specific VST Infusion Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons NCT07050732Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Arexvy (2 doses total), Arexvy (3 doses total), Arexvy (1 dose total), Placebo Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) NCT05909332Phase 315 sites📍 Beijing📍 Chongqing📍 Fuzhou Fudan University · Tests: Antivascular therapy, Chemotherapy Viral Infections in Healthy and Immunocompromised Hosts NCT01306084n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients NCT07321808n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria NCT06652126n/a1 site📍 Lille University Hospital, Lille · Tests: Microbiological examinations. Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC) NCT06574789Phase 27 sites📍 Sydney📍 Sydney📍 Brisbane Murdoch Childrens Research Institute · Tests: Standard dosing of IV ganciclovir, Personalised dosing of IV ganciclovir Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital NCT07299500n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients NCT06615635NA11 sites📍 Gilbert📍 Phoenix📍 Phoenix Alpha Tau Medical LTD. · Tests: DaRT seeds Personalized Immunological Score for the Prediction of Severe Infectious Events in Immunocompromised Patients and Tailored Management (PERISCOPE) NCT07379554n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients NCT07406217Phase 24 sites📍 Basel📍 Geneva📍 Lausanne Calmy Alexandra · Tests: Paxlovid 5 days, Paxlovid 10 days Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study NCT03808922Phase 328 sites📍 Duarte📍 Sacramento📍 Chicago Ansun Biopharma, Inc. · Tests: DAS181, Placebo, DAS181 COVID-19, DAS181 OL Aztreonam-Avibactam in Immunocompromised Hosts NCT07890480n/a1 site📍 Buenos Aires Centro de Educación Medica e Investigaciones Clínicas Norbe… · Tests: Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases NCT07275580Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Amoxicillin, Placebo Vaccine-induced Immunity in Immunocompromised Patients NCT06612515n/a1 site📍 Cologne University of Cologne Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area. NCT07682766n/a1 site📍 Torino University of Turin, Italy A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults NCT07768345Phase 317 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles Pfizer · Tests: RSVpreF Vaccine Shingrix in Renal Transplant Recipients NCT04128189Phase 34 sites📍 Aurora📍 Atlanta📍 Boston University of Colorado, Denver · Tests: Shingrix Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections NCT06387667NA1 site📍 Asyut New Valley University · Tests: Complete blood count, C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (AST…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy